TotalMarketCap

Scienture

SCNXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$5.180 M

$3.15 -7.79%

Close of 6 Nov 2026

As of 6 Nov 2026, Scienture (SCNX) has a market capitalization of $5.18M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$431.6K

#3517 by revenue

Earnings

-$41.5M

Loss-making

Shares outstanding

41,064,146

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #448PulmatrixPULM$5.31M
  2. #449Processa PharmaceuticalsPCSA$5.26M
  3. #450ScientureSCNX$5.18M
  4. #451GelteqGELS$4.88M
  5. #452ImunonIMNN$4.86M

What if Scienture were worth as much as…

Open the what-if tool →

Gold $28.2T

$17,190,708

Per share 5,451,311× higher

Bitcoin $1.53T

$930,159.30

Per share 294,961× higher

Apple $5.02T

$3,053,626

Per share 968,329× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Scienture are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.